Clinical Trial Update: HRD Tests for Ovarian cancER [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating homologous recombination deficiency (HRD) testing in ovarian cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING